NCT01827462View on ClinicalTrials.gov

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

PHASE4CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2017

Conditions
Influenza
Interventions
BIOLOGICAL

Trivalent, inactivated influenza vaccine (TIV)

Licensed Seasonal Influenza Vaccine TIV

BIOLOGICAL

Quadrivalent, inactivated influenza vaccine (IIV4)

Licensed Seasonal Influenza Vaccine IIV4

BIOLOGICAL

High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)

Licensed Seasonal High-Dose Influenza Vaccine TIV

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT01827462 - Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017) | Biotech Hunter | Biotech Hunter